Comparison of Onset of Efficacy of Therapies for Ulcerative Colitis Based on Patient Symptom Diary Data version 2

Ulcerative colitis (UC) is a chronic condition that causes inflammation in the colon and rectum, leading to symptoms such as diarrhea, rectal bleeding, and abdominal pain. These symptoms can significantly impact the quality of life for those affected. It is currently unclear how quickly patients with UC who respond to therapy can expect to have improvement in their symptoms. These symptoms can greatly affect a person's quality of life. Monitoring UC involves using patient-reported outcomes (PROs) like the PRO-2 score, which assesses symptom severity based on stool frequency and rectal bleeding.

Clinical trials in UC often present post-hoc analyses comparing daily symptom diaries between drug-treated and placebo-treated patients. These analyses include all patients, regardless of their response to the therapy, which may potentially dilute the observed effect. Therefore, it is difficult to extrapolate from these analyses how soon responders can expect to experience improvement in their symptoms. Moreover, it is unclear how therapies for UC compare with regards to the time to onset of symptom relief.

This study aims to compare the effectiveness of different therapies for UC by looking at how quickly patients experience symptom relief, using data reported by patients in daily symptom diaries. By focusing on patients who respond to treatment, the study provides valuable insights into how soon symptom improvement can be expected with various therapies, helping both physicians and patients make informed decisions about treatment options.